ロード中...
T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity
PURPOSE: Successful tumor eradication primarily depends on generation and maintenance of a large population of tumor-reactive CD8 T cells. Dendritic cells (DCs) are well-known potent antigen-presenting cells and have applied to clinics as potent antitumor therapeutic agents. However, high cost and d...
保存先:
| 出版年: | Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Cancer Association
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7373873/ https://ncbi.nlm.nih.gov/pubmed/32065848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2019.721 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|